Antimicrobial and anti-viral materials have attracted significant interest in recent years due to increasing occurrences of nosocomial infections and pathogenic microbial contamination. One method to address this is the combination of photoactive compounds that can produce reactive oxygen species (ROS), such as hydrogen peroxide and hydroxyl radicals to disinfect microbes, with carrier materials that meet the application requirements. Using anthraquinone (AQ) and cellulose nanocrystals (CNCs) as the photoactive and carrier components respectively, this work demonstrates the first covalent incorporation of AQ onto CNCs. The morphology and the photoactive properties were investigated, revealing the structural integrity of the CNCs, and high degree of photoactivity of AQ-CNC materials upon UVA exposure. The AQ-CNCs also exhibited an unexpected persistent generation of ROS under darkness, which adds advantages for antimicrobial applications.

Primary urethral malignancies are rare in clinical practice and elderly female are prone to suffer. The cause of PUC is unknown and may be related to long-term chronic inflammation, infection, sexual intercourse, pregnancy and irritation of the urethra. Incipient symptom of PUC is not distinctness and can easily lead to misdiagnosis. The final diagnosis relied on transvaginal ultrasound-guided mass biopsy and urethral biopsy. Early tumor treatment is mainly based on surgical resection. For advanced tumors, it is recommended to adopt a comprehensive treatment plan combining surgery, radiotherapy and chemotherapy We report this case with the aim of bringing attention to that primary urethral cancer progresses rapidly and has a poor prognosis, it is urged to call for a need of diagnostic and treatment specification.

To study the mechanism of light color on a sea urchin (Tripneustes gratilla), blue light (B, λ450nm), yellow light (Y, λ585-590nm), red light (R, λ640nm), green light (G, λ510nm), white light (W, λ400-780nm) and darkness groups (H) were set up in a seawater recirculating aquaculture system. Six different LED light color treatment groups with a photoperiod of 12 L:12 D were tested for 30 d to investigate the effects of different light colors on the feeding, growth and enzyme activities of T. gratilla (142.45±4.36 g). We found that varying LED light colors significantly impacts the feeding, growth, and enzyme activity of T. gratilla. Notably, the sea urchins in group B exhibited better growth with a weight gain rate of 39.26%, while those in group R demonstrated poorer growth with a weight gain rate of only 26%. The feeding differed significantly (P<0.01) between groups B and R, with group B consuming the highest daily intake (6.03±1.69 g) and group R consuming the lowest (4.54±1.26 g). Throughout the three phases, there was no significant change in the viability of the AMS (P>0.05). Conversely, pepsin viability significantly increased (P<0.01) in group B. LPS viability remained consistently at the lowest level, with no notable differences in group W from those observed in group B. In group R, both AMS and pepsin viability remained lower, whereas lipase viability was noticeably higher in each phase compared to group B (P<0.01). Regarding antioxidant enzymes, group R exhibited a trend of initially increasing and then decreasing CAT, SOD, and GSH-PX activities, particularly during the third stage (15-30 d), with a significant decrease observed in antioxidant enzyme activities (P<0.01). The outcomes suggest that blue light positively affects the growth, feeding, digestion, and antioxidant capacity of T. gratilla in comparison to other light environments, whereas the red light has an inhibitory impact.

LR004 is a novel chimeric (human/mouse) monoclonal antibody developed for the treatment of advanced colorectal carcinoma with detectable epidermal growth factor receptor (EGFR) expression. We aimed to investigate the preclinical pharmacokinetics (PK) and in vivo biodistribution of LR004. The PK profiles of LR004 were initially established in rhesus monkeys. Subsequently, 125I radionuclide-labeled LR004 was developed and its binding activity to the EGFR antigen were evaluated. Furthermore, the biodistribution, autoradiography, and NanoSPECT/CT of 125I-LR004 in xenograft mice bearing A431 tumors were examined. The PK data revealed a prolonged half-life and nonlinear PK characteristics of LR004 within the dose range of 6–54 mg/kg. The radiochemical purity of 125I-LR004 was approximately 98.54%, and iodination of LR004 did not affect its specific binding activity to the EGFR antigen. In a classical biodistribution study, 125I-LR004 exhibited higher uptake in highly perfused organs than in poorly perfused organs. Prolonged retention properties of 125I-LR004 in tumors were observed at 4 and 10 days. Autoradiography and NanoSPECT/CT confirmed the significant accumulation and sustained retention of 125I-LR004 at the tumor site in xenograft mice. These findings demonstrated the adequate tumor targeting capabilities of 125I-LR004 in EGFR-positive tumors, which may improve dosing strategies and future drug development.